RNS Number : 1809Y
Stenprop Limited
30 December 2019
 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP

ISIN:  GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS BY AN ASSOCIATE OF A DIRECTOR OF THE COMPANY

 

 

30 December 2019

 

Shareholders are advised of the following information relating to the sale of Company's securities by an associate of a director:  

 

Name of associate

Millicent Limited

Name of director:

Patsy Watson, who is the discretionary beneficiary of the Swallow Trust, which has a beneficial interest in Millicent Limited 

Transaction date:

20 December 2019

Class of securities:

Ordinary shares

Number of securities sold:

50,000

Price per security:

GBP 1.27

Deemed total value of the transaction:

GBP 63,500

Nature of transaction:

 

 

Nature and extent of director's interest:

 

On-market sale on the London Stock Exchange, through SP Nominees Limited, a nominee company which holds shares on behalf of Millicent Limited

Indirect beneficial

 

 

For further information:

 

Stenprop Limited

James Beaumont
Paul Arenson

Julian Carey

44(0)20 3918 6600

 

Numis Securities Limited (Financial Adviser)

Hugh Jonathan
Vicki Paine

44(0)20 7260 1000

 

JSE Sponsor

Java Capital Trustees and Sponsors Proprietary Limited

27(0)11 722 3050

 

 

 

About Stenprop

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKFDNFBDDPBB